My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Resolution 2024-069
>
Meetings
>
2024
>
04. April
>
2024-04-16 10:00 AM - Commissioners' Agenda
>
Resolution 2024-069
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/22/2024 9:25:50 AM
Creation date
5/22/2024 9:24:53 AM
Metadata
Fields
Template:
Meeting
Date
4/16/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Fully Executed Version
Supplemental fields
Item
Request to Approve a Resolution Accepting the Johnson & Johnson (Janssen) Washington State State-Wide Opioid Settlement Agreement
Order
7
Placement
Consent Agenda
Row ID
116716
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
130
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
o <br />P <br />a <br />For the Attorney General: <br />Jeffrey G. Rupert <br />Martha Rodriguez L6pez <br />Susan Llorens <br />Office of the Washington Attorney General <br />800 Fifth Avenue, Suite 2000 <br />Seattle, WA 98104 <br />Jef frey. Rupert@atg.wa. gov <br />Marth a. Ro dri gu ezlop e z@atg.w a. gov <br />S usan.Llorens@atg.wa. gov <br />and <br />Brad Beckworth <br />Drew Pate <br />Nix Patterson LLP <br />8701 Bee Caves Road, Building l, Suite 500 <br />Austin, Texas 78746 <br />bbeckworth@nixlaw. com <br />dpate@nixlaw.com <br />Any Party may change or add the contact information of the persons designated to receive <br />notice on its behalf by notice given (effective upon the giving of such notice) as provided in <br />this subsection. <br />No Waiver. The waiver of any rights conferred hereunder shall be effective only if made by <br />written instrument executed by the waiving Party or Parties. The waiver by any Party of any <br />breach of this Agreement shall not be deemed to be or construed as a waiver of any other <br />breach, whether prior, subsequent, or contemporaneous, nor shall such waiver be deemed to <br />be or construed as a waiver by any other Pafty. <br />Preservation of Privilege. Nothing contained in this Agreement or any Consent Judgment, <br />and no act required to be performed pursuant to this Agreement or any Consent Judgment, is <br />intended to constitute, cause, or effect any waiver (in whole or in part) of any attorney-client <br />privilege, work product protection, or common interest/joint defense privilege, and each <br />Party agrees that it shall not make or cause to be made in any forum any assertion to the <br />contrary. <br />Successors. This Agreement shall be binding upon, and inure to the benefit of, Janssen and <br />its respective successors and assigns. Janssen shall not sell the majority of its voting stock or <br />substantially all its assets without obtaining the acquiror's agreement that it will constitute a <br />successor with respect to Janssen's obligations under this Agreement. <br />Modification, Amendment, Alteration. This Agreement may be modified, amended, or <br />altered by a written agreement of the Parlies or, in the case of the Consent Judgment, by <br />R. <br />l7
The URL can be used to link to this page
Your browser does not support the video tag.